Lomustine Capsule, Gelatin Coated
Product Images NDC 52536-340

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lomustine (NDC 52536-340). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wilshire Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg-carton (100mg Carton)

Packaging label for Lomustine Capsules, USP 100 mg per capsule, oral gelatin-coated capsules. The carton indicates a package size of 5 capsules, labeled as a cytotoxic agent with caution to wear gloves when handling. Storage instructions specify maintaining 25°C with permitted excursions, avoiding excessive heat and light exposure. Manufactured for Wilshire Pharmaceuticals, Inc., with additional manufacturer information noted.*

FDA Label Image

100mg-label (100mg Label)

Lomustine Capsules, USP 100 mg per capsule gelatin-coated oral capsules by Wilshire Pharmaceuticals, Inc. The label indicates a package of 5 capsules and includes handling cautions and usual adult dosage instructions. The label emphasizes dispensing only the needed capsules per dose and storage conditions.*

FDA Label Image

10mg-carton (10mg Carton)

Packaging label for Lomustine Capsules, USP 10 mg per capsule, gelatin-coated oral capsules. The carton is labeled for 5 capsules and includes cautionary instructions to dispense only enough capsules for one dose. It is marked as a cytotoxic agent with storage instructions and manufacturer information for Wilshire Pharmaceuticals, Inc.*

FDA Label Image

10mg (10mg)

Label for Lomustine Capsules, USP 10 mg per capsule, oral gelatin-coated capsules. The package contains 5 capsules. Label includes warnings about cytotoxicity and storage instructions. Manufactured by Wilshire Pharmaceuticals, Inc., with mention of manufacturing by Latina Pharma S.p.A. in Italy.*

FDA Label Image

40mg-label (40mg Label)

Lomustine Capsules, USP 40 mg per capsule gelatin-coated oral capsules, labeled for a package of 5 capsules. The label includes handling cautions noting the drug is cytotoxic, a dosage warning not to dispense the entire container at once, and storage instructions. Manufactured by Wilshire Pharmaceuticals, Inc.*

FDA Label Image

40mg-carton (40mg)

Packaging label for Lomustine Capsules, USP 40 mg per capsule, containing 5 capsules. Label highlights the cytotoxic nature with caution to wear gloves when handling. Storage instructions specify 25°C with allowable excursions. The labeler is Wilshire Pharmaceuticals, Inc., with manufacturing by Latina Pharma S.p.A. Includes barcodes, lot number, and NDC 52536-341-05.*

FDA Label Image

Structure (Gle00 0008 01)

Chemical structure diagram of the active ingredient lomustine, showing the molecular arrangement including chlorine, nitroso, and other functional groups.*

FDA Label Image

Wilshire-logo (Wilshire Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.